Andersen A,Warren DJ,Brunsvig PF,Aamdal S,Kristensen GB,Olsen H GB .2006 .High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection. BMC Clin. Pharmacol, 6(2) : 1472.
Bardelmeijer HA,Ouwehand M,Beijnen JH,Schellens JHM,Tellingen OV .2004 .Efficacy of novel Pglycoprotein inhibitors to increase the oral uptake of paclitaxel in mice. Invest. New Drugs, 22 : 219-229.
Foa R,Norton L,Seidman AD .1994 .Taxol (paclitaxel): A novel anti-microtubule agent with remarkable anti-neoplastic activity. Int. J. Clin. Lab. Res., 24(1) : 6-14.
Gao P,Rush BD,Pfund WP,Huang T,Bauer JM,Morozowich M,Kuo MS,Hageman MJ MS .2003 .Development of a supersaturable SEDDS (S-SEDDS) formulation of paclitaxel with improved oral bioavailability. J. Pharm. Sci., 92(12) : 2386-98.
ICH .2005 .Guideline-Validation of Analytical Procedures:Text and Methodology Q2(R1), Current Step 4 version. , : .
Jain A,Gulbake A,Jain A,Shilpi A,Hurkat P,Kashaw S,Jain S S .2014 .Development and validation of the hplc method for simultaneous estimation of paclitaxel and topotecan. J. Chromatogr. Sci., 52(7) : 697-703.
Javed A,Kanchan K,Showkat RM,Saima A .2013 .Development and validation of RP-HPLC method for analysis of novel self-emulsifying paclitaxel formulation. Research and Reviews: J. Pharm. Anal, 2(3) : 17-27.
Kesharwani P,Tekade RK,Jain NJ .2011 .Spectrophotometric estimation of paclitaxel. Int. J. Adv. Pharm. Sci. 2, (1) : 29-32.
Montazeri AS,Mohammadi A,Adib N,Naeemy A .2018 .Development and validation of a stabilityindicating HPLC method for the determination of acarbose in pharmaceutical dosage forms. J. Anal. Chem, 73(9) : 910-916.
Mowafy H,Alanazi F,Alsarra IA,Maghraby GE,Kazi M .2012 .Method for determination of paclitaxel in rabbit plasma. Asian J. Chem, 24(8) : 3352-3356.
Musteata FM,Pawliszyn J .2006 .Determination of free concentration of paclitaxel in liposome formulation. J. Pharm. Pharm. Sci., 9(2) : 231-237.
Prashanth S,Kumar AA,Madhu B,Sagar JV B .2011 .LC and LC-MS study on stress decomposition behavior of paclitaxeland establishment of validated stabilityindicating assay method. Int. J. Pharm. Sci. Drug Res., 3(3) : 188-196.
Pyla S,Srinivas K,Yvv J,Panda J .2013 .Development and validation of new analytical method for paclitaxel in bulk and pharmaceutical dosage form by reverse phase HPLC (RP-HPLC). Int. J. Pharm. Bio. Sci., 4(3) : 534-540.
Sathyamoorthy N,Naveena VSH,Rajendran V,Dhanaraju MD .2014 .An approach for validated RPHPLC method for the analysis of paclitaxel in rat plasma. J. Appl. Pharm., 4(9) : 73-76.
Siddiqui S,Pallwal S,Kohi K,Siddiqui AA,Sahu K AA .2012 .RP-HPLC method for estimation and stress degradation study of paclitaxel as per ICH guidelines. J. Chromat. Separation Techniq, 3(4) : 1-4.
Srinivasa MS,Chandan RS,Koganti VS .2017 .Validated RP-UFLC method development of paclitaxel in pure and pharmaceutical dosage form. Pharm Methods, 8(1) : 155-159.
Wang F,Porter M,Konstantopoulos A,Zhang P,Cui H P .2017 .Preclinical development of drug delivery systems for paclitaxel-based cancer chemotherapy. J. Control. Release, 267(3) : 100-118.
Zhai J,Luwor R B,Ahmed N,Escalona R,Tan FH,Fong C,Ratcliffe J,Scoble JA,Drummond C J,Tran N C J .2018 .Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer. ACS Appl. Mater. Interfaces, 10(30) : 25174-25185.